EPIDEMIOLOGY AND CANCER CONTROL

流行病学和癌症控制

• 批准号: 8436432
• 负责人: William L. Carroll
• 金额: $ 2.34万
• 依托单位: NEW YORK UNIVERSITY SCHOOL OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-03-01 至 2018-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8436432
• 关键词: Address; Area; Biological Markers; Cancer Burden; Cancer Center Support Grant; Cancer Control; Cancer Control Research; Cancer Control Research Program; Cancer Etiology; Cancer Patient; Cancer Survivor; Cessation of life; Clinical; Collaborations; Development; Early Diagnosis; Environmental Risk Factor; Epidemiology; Funding; Genetic Determinism; Goals; Health; Hospitals; Human Genetics; Human Microbiome; Instruction; Kaplan Cancer Center; Laboratories; Malignant Neoplasms; Metabolic; Methods; Mission; Modification; New York; New York City; Obesity; Patients; Population; Publications; Quality of life; Reproductive History; Research; Research Institute; Research Personnel; Risk Factors; Role; Scientist; Screening for cancer; Survivors; Tobacco use; Underserved Population; United States Department of Veterans Affairs; cancer prevention; cancer risk; community organizations; evidence base; improved; meetings; member; novel; outreach; population based; programs; screening; tumor progression

PROJECT SUMMARY (See instructions); The Epidemiology & Cancer Control Program is composed of 34 investigators (30 Full and 4 Associate members) from 12 Departments. The overall mission of the Program is to reduce the risk of cancer occurrence and death and to enhance the quality of life of cancer survivors. To fulfill this mission, it has 4 major scientific objectives: 1) To identify environmental and genetic determinants of cancer to improve means of cancer prevention, focusing specifically on understanding the role of environmental factors in cancer etiology, determining the metabolic and reproductive factors in cancer etiology, understanding the role of human genetics in cancer etiology and progression, and identifying cancer risks associated with the human microbiome; 2) To reduce cancer burden by risk factor modification, with a specific focus on obesity control and tobacco use reduction; 3) To reduce cancer burden by early detection of cancer, with a specific focus on the application of methods to increase screening participation by underserved populations and the development of novel early detection biomarkers; and 4) To address cancer-related burden in patients and survivors, with a particular emphasis on meeting the needs of the underserved. The research focus areas are interdisciplinary, including population, laboratory and clinical scientists from ECC and other NYU CancerInstitute Research Programs. Drs. Richard Hayes and Brian Schmidt are the Co-Leaders for this Program. This is a new Program that currently has $16,940,943 on funding. Publications for the period total 216, of which 17.6% are intra-programmatic, 11.1% are inter-programmatic, and 8.8% are both intra- and interprogrammatic collaborations.

项目摘要（参见说明）； 流行病学和癌症控制项目由来自 12 个部门的 34 名研究人员（30 名正式成员和 4 名准成员）组成。该计划的总体使命是降低癌症发生和死亡的风险，并提高癌症幸存者的生活质量。为了完成这一使命，它有4个主要科学目标：1）确定癌症的环境和遗传决定因素，以改善癌症预防手段，特别侧重于了解环境因素在癌症病因中的作用，确定癌症病因中的代谢和生殖因素，了解人类遗传学在癌症病因和进展中的作用，以及识别与人类微生物组相关的癌症风险； 2) 通过改变危险因素来减少癌症负担，特别关注肥胖控制和减少烟草使用； 3) 通过早期检测癌症来减轻癌症负担，特别注重应用方法来增加服务不足人群的筛查参与度以及开发新型早期检测生物标志物； 4) 解决患者和幸存者与癌症相关的负担，特别强调满足服务不足人群的需求。研究重点领域是 跨学科的，包括来自 ECC 和其他纽约大学癌症研究所研究项目的人口、实验室和临床科学家。博士。理查德·海斯 (Richard Hayes) 和布莱恩·施密特 (Brian Schmidt) 是该计划的联合领导者。 这是一项新计划，目前资金为 16,940,943 美元。该期间出版物总数为 216 篇，其中 17.6% 为项目内出版物，11.1% 为项目间出版物，8.8% 为项目内合作和项目间合作。